Dr. Mignot has received research support and speaker honorarium from Cephalon and Orphan Medical; and is a stock holder and advisor of Hypnion, a biotechnology company. Drs. Cizza and Skarulis have indicated no financial conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Cizza et al. (2005) studied this question.